AVROXA

Technologiepark-Zwijnaarde 82

9052 Gent

BE

AVROXA

Foundation date

10/01/2018

Sector

#Medical Technology

Subsector

AVROXA is a research and manufacturing company committed to the development of innovative solutions based on our versatile proprietary polymer platform technology of poly(2-oxazoline)s (abbreviated as POZ, PAOx,POX). We develop a vast range of high-quality, well-defined, ultra-pure poly(2-oxazoline)s under the brandname ULTROXA(R) for applications in therapeutics, drug delivery, biomaterials and diagnostics.

Upcoming events

Latest news

  • Celyad Oncology appoints Georges Rawadi as its new CEO

    Tuesday March 28th 2023

  • BioLizard appoints Paul Vauterin as Chief Technology Officer

    Monday March 27th 2023

  • ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI

    Monday March 27th 2023